| Min Pa: | Min Pa(max): | Activity's type: |
| Ext | Pa | Pi | Pmax | Activity | Other Results | ID Pa_max |
|---|---|---|---|---|---|---|
| 0.585 | 0.005 | 0.585 | Diuretic | 0.498 0.008 CID_14475217 | ||
| 0.404 | 0.028 | 0.404 | Cardiotonic | 0.375 0.034 CID_14475217 | ||
| 0.35 | 0 | 0.35 | Bombesin 3 receptor antagonist | 0.308 0.001 CID_14475217 | ||
| 0.341 | 0.027 | 0.341 | Ca2+/calmodulin-dependent kinase I alpha inhibitor | 0.267 0.053 CID_14475217 | ||
| 0.284 | 0.021 | 0.284 | Focal adhesion kinase 2 inhibitor | 0.196 0.073 CID_14475217 | ||
| 0.28 | 0.06 | 0.352 | Hypoglycemic | 0.352 0.037 CID_14475217 | CID_14475217 | |
| 0.221 | 0.003 | 0.221 | Bombesin antagonist | 0.183 0.004 CID_14475217 | ||
| 0.253 | 0.036 | 0.253 | LIM domain kinase 1 inhibitor | 0.179 0.074 CID_14475217 | ||
| 0.214 | 0.004 | 0.214 | Potassium channel (ATP-sensitive) blocker | 0.168 0.004 CID_14475217 | ||
| 0.221 | 0.035 | 0.221 | Polo-like kinase-3 inhibitor | 0.19 0.051 CID_14475217 | ||
| 0.188 | 0.002 | 0.188 | Potassium channel Kv1.1 blocker | 0.085 0.005 CID_14475217 | ||
| 0.189 | 0.013 | 0.189 | ALK inhibitor | 0.137 0.023 CID_14475217 | ||
| 0.23 | 0.056 | 0.23 | MAP kinase kinase 3 inhibitor | 0.207 0.104 CID_14475217 | ||
| 0.176 | 0.002 | 0.176 | Carbonic anhydrase I stimulant | 0.155 0.003 CID_14475217 | ||
| 0.17 | 0.002 | 0.17 | Bombesin agonist | 0.157 0.002 CID_14475217 | ||
| 0.16 | 0.003 | 0.16 | Carbonic anhydrase II stimulant | 0.142 0.003 CID_14475217 | ||
| 0.147 | 0.002 | 0.147 | Bombesin 3 receptor agonist | 0.135 0.002 CID_14475217 | ||
| 0.142 | 0.005 | 0.142 | ZAP-70 protein tyrosine kinase inhibitor | 0.123 0.007 CID_14475217 | ||
| 0.14 | 0.005 | 0.179 | Thromboxane antagonist | 0.179 0.004 CID_14475217 | CID_14475217 | |
| 0.321 | 0.186 | 0.321 | Ca2+/calmodulin-dependent protein kinase kinase A inhibitor | |||
| 0.144 | 0.013 | 0.144 | Carbonic anhydrase XII inhibitor | 0.129 0.015 CID_14475217 | ||
| 0.186 | 0.056 | 0.186 | Dual specificity tyrosine-phosphorylation-regulated kinase 4 inhibitor | 0.122 0.1 CID_14475217 | ||
| 0.217 | 0.09 | 0.263 | Platelet antagonist | 0.263 0.067 CID_14475217 | CID_14475217 | |
| 0.148 | 0.024 | 0.148 | CC chemokine 6 receptor antagonist | 0.142 0.035 CID_14475217 | ||
| 0.122 | 0.005 | 0.161 | Thromboxane A2 antagonist | 0.161 0.004 CID_14475217 | CID_14475217 | |
| 0.171 | 0.054 | 0.171 | Protein kinase (CK1) gamma 1 inhibitor | |||
| 0.198 | 0.082 | 0.198 | Platelet aggregation inhibitor | 0.178 0.099 CID_14475217 | ||
| 0.13 | 0.015 | 0.13 | Carbonic anhydrase IX inhibitor | 0.118 0.016 CID_14475217 | ||
| 0.128 | 0.015 | 0.128 | Thrombin inhibitor | 0.113 0.02 CID_14475217 | ||
| 0.222 | 0.112 | 0.222 | Ca2+/calmodulin-dependent kinase IV inhibitor | 0.196 0.177 CID_14475217 | ||
| 0.122 | 0.014 | 0.122 | Carbonic anhydrase stimulant | 0.08 0.026 CID_14475217 | ||
| 0.116 | 0.022 | 0.116 | Carbonic anhydrase inhibitor | 0.112 0.023 CID_14475217 | ||
| 0.186 | 0.098 | 0.186 | EphB2 antagonist | |||
| 0.084 | 0.002 | 0.084 | Carbonic anhydrase IV stimulant | 0.07 0.002 CID_14475217 | ||
| 0.151 | 0.074 | 0.161 | Insulin secretagoues | 0.161 0.063 CID_14475217 | CID_14475217 | |
| 0.128 | 0.052 | 0.128 | Interleukin 8 antagonist | |||
| 0.139 | 0.066 | 0.139 | Aurora-C kinase inhibitor | 0.133 0.076 CID_14475217 | ||
| 0.1 | 0.03 | 0.1 | Focal adhesion kinase 1 inhibitor | 0.083 0.046 CID_14475217 | ||
| 0.165 | 0.101 | 0.165 | Death-associated protein kinase 3 inhibitor | |||
| 0.096 | 0.037 | 0.115 | Somatostatin 1 agonist | 0.115 0.025 CID_14475217 | CID_14475217 | |
| 0.074 | 0.015 | 0.074 | Potassium channel (Inward rectifier) blocker | 0.057 0.026 CID_14475217 | ||
| 0.132 | 0.079 | 0.132 | Protein kinase (CK1) gamma inhibitor | |||
| 0.061 | 0.015 | 0.061 | Collagenase inhibitor | 0.058 0.019 CID_14475217 | ||
| 0.244 | 0.198 | 0.244 | MAP kinase kinase 6 inhibitor | |||
| 0.214 | 0.169 | 0.237 | Sodium/bile acid cotransporter inhibitor | 0.237 0.143 CID_14475217 | CID_14475217 | |
| 0.143 | 0.098 | 0.143 | Protein kinase (CK1) gamma 3 inhibitor | |||
| 0.061 | 0.017 | 0.061 | Fructose-1,6-bisphosphatase inhibitor | |||
| 0.071 | 0.028 | 0.071 | Carbonic anhydrase I inhibitor | 0.063 0.033 CID_14475217 | ||
| 0.06 | 0.02 | 0.06 | Potassium channel (Inward rectifier) activator | |||
| 0.075 | 0.037 | 0.075 | Bcl2 antagonist | 0.073 0.038 CID_14475217 | ||
| 0.145 | 0.108 | 0.166 | Cyclin-dependent kinase 3 inhibitor | 0.166 0.066 CID_14475217 | CID_14475217 | |
| 0.068 | 0.031 | 0.068 | Carbonic anhydrase II inhibitor | 0.061 0.034 CID_14475217 | ||
| 0.047 | 0.01 | 0.047 | Angiotensin AT2 receptor antagonist | 0.047 0.01 CID_14475217 | ||
| 0.06 | 0.024 | 0.076 | Beta 2 adrenoreceptor antagonist | 0.076 0.013 CID_14475217 | CID_14475217 | |
| 0.056 | 0.02 | 0.056 | Potassium channel (ATP-sensitive) activator | |||
| 0.056 | 0.023 | 0.056 | Aldosterone antagonist | |||
| 0.098 | 0.073 | 0.098 | Factor V inhibitor | 0.098 0.073 CID_14475217 | ||
| 0.056 | 0.035 | 0.061 | Thromboxane synthase inhibitor | 0.061 0.026 CID_14475217 | CID_14475217 | |
| 0.078 | 0.061 | 0.078 | Neuropeptide Y antagonist | |||
| 0.027 | 0.01 | 0.027 | Fructose-1,6-bisphosphatase 1 inhibitor | |||
| 0.049 | 0.034 | 0.084 | Carbonic anhydrase XIV inhibitor | 0.084 0.015 CID_14475217 | CID_14475217 | |
| 0.02 | 0.005 | 0.02 | CC chemokine 10 receptor antagonist | 0.017 0.006 CID_14475217 | ||
| 0.026 | 0.011 | 0.05 | Beta 1 adrenoreceptor agonist | 0.05 0.004 CID_14475217 | CID_14475217 | |
| 0.024 | 0.011 | 0.024 | Angiotensin AT1A receptor antagonist | 0.024 0.011 CID_14475217 | ||
| 0.054 | 0.042 | 0.073 | Beta 1 adrenoreceptor antagonist | 0.073 0.023 CID_14475217 | CID_14475217 | |
| 0.141 | 0.129 | 0.141 | MAP kinase kinase 2 inhibitor | |||
| 0.032 | 0.025 | 0.032 | Purinergic P2Y2 antagonist | |||
| 0.079 | 0.073 | 0.079 | Protein kinase (Mos, Mil/Raf, MEKK, RIPK, TESK, LIMK, IRAK, ILK, Activin/TGF-beta) inhibitor | |||
| 0.079 | 0.077 | 0.079 | Potassium channel activator | |||
| 0.035 | 0.039 | 0.039 | Aggrecanase 1 inhibitor | 0.039 0.028 CID_14475217 | CID_14475217 | |
| 0.053 | 0.06 | 0.064 | Neutrophil collagenase inhibitor | 0.064 0.046 CID_14475217 | CID_14475217 | |
| 0.021 | 0.032 | 0.026 | Prostaglandin EP3 antagonist | 0.026 0.025 CID_14475217 | CID_14475217 | |
| 0.038 | 0.051 | 0.067 | Prostaglandin E2 antagonist | 0.067 0.025 CID_14475217 | CID_14475217 | |
| 0.065 | 0.081 | 0.138 | Adrenaline agonist | 0.138 0.018 CID_14475217 | CID_14475217 | |
| 0.006 | 0.022 | 0.015 | Beta 3 adrenoreceptor agonist | 0.015 0.006 CID_14475217 | CID_14475217 | |
| 0.053 | 0.069 | 0.074 | Beta adrenoreceptor antagonist | 0.074 0.033 CID_14475217 | CID_14475217 | |
| 0.038 | 0.073 | 0.053 | Beta adrenoreceptor agonist | 0.053 0.013 CID_14475217 | CID_14475217 | |
| 0.164 | 0.229 | 0.255 | Antithrombotic | 0.255 0.122 CID_14475217 | CID_14475217 | |
| 0.048 | 0.128 | 0.067 | Beta 2 adrenoreceptor agonist | 0.067 0.025 CID_14475217 | CID_14475217 | |
| 0.034 | 0.129 | 0.053 | Glucosylceramidase inhibitor | 0.053 0.041 CID_14475217 | CID_14475217 | |
| 0.153 | 0.354 | 0.295 | Cyclophilin D inhibitor | 0.295 0.167 CID_14475217 | CID_14475217 | Ext | Pa | Pi | Pmax | Activity | Other Results | ID Pa_max |